Novartis M&A Summary
Novartis has acquired 40 companies, including 15 in the last 5 years. A total of 9 acquisitions came from private equity firms. It has also divested 8 assets.
Novartis’ largest acquisition to date was in 2025, when it acquired Avidity Biosciences for $12.0B. It’s largest disclosed sale occurred in 2014, when it sold Novartis Animal Health to Eli Lilly and Co. for $5.4B. Novartis has acquired in 11 different US states, and 6 countries. The Company’s most targeted sectors include life science (84%) and medical products (9%).
M&A Summary
-
M&A Total Activity44
- M&A Buy Activity36
- M&A Sell Activity8
- Total Sectors Invested 4
- Total Countries Invested 6
- M&A Buy/Sell Connections 21